ChristopherUweJonesMD

Radiation Oncology • Roseville, CA

Physician

Join to view full profile

Dr. Jones is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Jones' full profile

Already have an account?

Office
2 Medical Plaza Dr
Ste 180
Roseville, CA 95661
Phone+1 916-781-1225

Fax+1 916-797-4799
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1987 - 1990
Loyola Medicine MacNeal HospitalInternship, Transitional Year, 1986 - 1987
Rush Medical College of Rush University Medical CenterClass of 1986

Certifications & Licensure

CA State Medical License 1991 - 2025
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2009 Nov 01
Active, not recruiting
Phase 3
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
Active, not recruiting
Phase 3
Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2010 Mar 01
Completed
Phase 2
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer Start of enrollment: 2012 May 01
Active, not recruiting
Phase 3
TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer. Start of enrollment: 2013 Mar 15
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

3 citations
Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostate Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521...
Oliver Sartor, Theodore G Karrison, Howard M Sandler, Leonard G Gomella, Mahul B Amin, James Purdy, Jeff M Michalski, Mark G Garzotto, Nadeem Pervez, Alexander G Balog...> ;European Urology. 2023 Aug 1
26 citations
Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of t...
Ting Martin Ma, Fang-I Chu, Howard Sandler, Felix Y Feng, Jason A Efstathiou, Christopher U Jones, Mack Roach 3rd, Seth A Rosenthal, Thomas Pisansky, Jeff M Michalski,...> ;European Urology. 2022 Nov 1
9 citations
Comparison of Response to Definitive Radiotherapy for Localized Prostate Cancer in Black and White Men: A Meta-analysis.
Ting Martin Ma, Tahmineh Romero, Nicholas G Nickols, Matthew B Rettig, Isla P Garraway, Mack Roach 3rd, Jeff M Michalski, Thomas M Pisansky, W Robert Lee, Christopher ...> ;JAMA Network Open. 2021 Dec 1
Final Report of NRG Oncology RTOG 0022: A Phase I/II Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer.
Adam S. Garden, Jonathan Harris, A. Eisbruch, K.S.C. Chao, William H. Morrison, Paul M. Harari, T A Swanson, Christopher U. Jones, Sue S. Yom, Sharon A. Spencer, Rufus...> ;International Journal of Radiation Oncology Biology Physics. 2021 Nov 1
17 citations
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical Tr...
Christopher U. Jones, Stephanie L. Pugh, Howard M. Sandler, Michael Chetner, Mahul B. Amin, Deborah Watkins Bruner, Anthony L. Zietman, Robert B. Den, Mark H. Leibenha...> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Sep 1
5 citations
The impact of age on outcome in phase III NRG Oncology/RTOG trials of radiotherapy (XRT) +/- systemic therapy in locally advanced head and neck cancer.
Julie A. Kish, Qiang Zhang, Corey J. Langer, Phuc Felix Nguyen-Tân, David I. Rosenthal, Randal S. Weber, Marcy A. List, Stuart J. Wong, Adam S. Garden, Kenneth S. Hu, ...> ;Journal of Geriatric Oncology. 2021 Apr 2
138 citations
Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)
Sue S. Yom, Pedro A. Torres-Saavedra, Jimmy J. Caudell, John Waldron, Maura L. Gillison, Ping Xia, Minh Tam Truong, Christina S. Kong, Richard C.K. Jordan, Rathan M. S...> ;Journal of Clinical Oncology. 2021 Jan 28
5 citations
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902.
Daniel A. Hamstra, Stephanie L. Pugh, Herbert Lepor, Seth A. Rosenthal, Kenneth J. Pienta, Leonard G. Gomella, Christopher A. Peters, David D'Souza, Kenneth L. Zeitzer...> ;Radiotherapy and Oncology. 2019 Dec 1
18 citations
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer.
Loren K. Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, David I. Rosenthal, Kaveh Zakeri, Lucas K. Vitzthum, Steven J. Frank, Peter B. Schiff, Andy Trotti, James A. Bonner,...> ;Clinical Cancer Research. 2019 Dec 1
43 citations
Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion
David J. Adelstein, Nofisat Ismaila, Jamie A. Ku, Barbara Burtness, Paul L. Swiecicki, Loren K. Mell, Jonathan J. Beitler, Neil D. Gross, Christopher U. Jones, Marnie ...> ;Journal of Clinical Oncology. 2019 Apr 25
6 citations
Trends in vaccine investment in middle income countries
Kateryna Onishchenko, Sophie Hill, Matt Wasserman, Christopher U. Jones, Margaret Moffatt, L. Ruff, Sarah J. Pugh> ;Human Vaccines & Immunotherapeutics. 2019 Apr 12
703 citations
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L. Gillison, Andy Trotti, Jonathan Harris, Avraham Eisbruch, Paul M. Harari, David J. Adelstein, Richard C.K. Jordan, Weiqiang Zhao, Erich M. Sturgis, Barbara Bu...> ;Lancet. 2019 Jan 5
1 citations
In Regard to Bossi et al.
Carole Fakhry, Phuc Felix Nguyen-Tân, Louise Lambert, David I. Rosenthal, Randal S. Weber, Maura L. Gillison, Andy Trotti, William L. Barrett, Wade L. Thorstad, Christ...> ;International Journal of Radiation Oncology, Biology, Physics. 2018 Nov 1
140 citations
Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial
Mack Roach, Jennifer Moughan, Colleen A. Lawton, Adam P. Dicker, Kenneth L. Zeitzer, Elizabeth Gore, Young Kwok, Michael J. Seider, I-Chow Hsu, Alan C. Hartford, Eric ...> ;The Lancet. Oncology. 2018 Nov 1
24 citations
NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients
Arif Ali, Peixin Zhang, W. K. Alfred Yung, Yuhchyau Chen, Benjamin Movsas, Raul C. Urtasun, Christopher U. Jones, Kwang N. Choi, Jeff M. Michalski, A. Jennifer Fischba...> ;Journal of Neuro-Oncology. 2018 Mar 1
11 citations
Serum testosterone changes in patients treated with radiation therapy alone for prostate cancer on NRG oncology RTOG 9408
R. Charles Nichols, Chen Hu, Jean Paul Bahary, Kenneth L. Zeitzer, Luis Souhami, Mark H. Leibenhaut, Marvin Rotman, Elizabeth Gore, Alexander Balogh, David G. McGowan,...> ;Advances in Radiation Oncology. 2017 Aug 3
103 citations
Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.
Carole Fakhry, Qiang Zhang, Phuc Felix Nguyen-Tân, David I. Rosenthal, Randal S. Weber, Louise Lambert, Andy Trotti, William L. Barrett, Wade L. Thorstad, Christopher ...> ;Journal of Clinical Oncology. 2017 Aug 4
28 citations
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With ...
Minh Tam Truong, Qiang Zhang, David I. Rosenthal, M. A. List, Rita Axelrod, Eric J. Sherman, Randal S. Weber, Phuc Felix Nguyen-Tân, Adel K. El-Naggar, Andre Konski, J...> ;International Journal of Radiation Oncology, Biology, Physics. 2017 Mar 15
28 citations
Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Standard Radiation Versus Accelerated Radi...
Canhua Xiao, Qiang Zhang, Phuc Felix Nguyen-Tân, M. A. List, Randal S. Weber, K. Kian Ang, David I. Rosenthal, Edith Filion, Harold Kim, Craig L. Silverman, Adam Raben...> ;International Journal of Radiation Oncology, Biology, Physics. 2017 Mar 15
17 citations
ACR appropriateness criteria ® nasal cavity and paranasal sinus cancers
Farzan Siddiqui, Richard V. Smith, Sue S. Yom, Jonathan J. Beitler, Paul M. Busse, Jay S. Cooper, Ehab Y. Hanna, Christopher U. Jones, Shlomo A. Koyfman, Harry Quon, J...> ;Head & Neck. 2017 Mar 1
14 citations
Acute and late urinary toxicity following radiation in men with an intact prostate gland or after a radical prostatectomy: A secondary analysis of RTOG 94-08 and 96-01.
Raymond H. Mak, Daniel Hunt, Jason A. Efstathiou, Niall M. Heney, Christopher U. Jones, Himu Lukka, Jean-Paul Bahary, Malti Patel, Alexander Balogh, Abdenour Nabid, Ma...> ;Urologic Oncology. 2016 Oct 1
14 citations
ACR Appropriateness Criteria ® Locoregional therapy for resectable oropharyngeal squamous cell carcinomas
Jonathan J. Beitler, Harry Quon, Christopher U. Jones, Joseph K. Salama, Paul M. Busse, Jay S. Cooper, Shlomo A. Koyfman, John A. Ridge, Nabil F. Saba, Farzan Siddiqui...> ;Head & Neck. 2016 Jun 22
27 citations
Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience
Voichita Bar-Ad, Q. Zhang, Paul M. Harari, Rita Axelrod, David I. Rosenthal, Andy Trotti, Christopher U. Jones, Adam S. Garden, Guobin Song, Robert L. Foote, David Rab...> ;International Journal of Radiation Oncology, Biology, Physics. 2016 Aug 1
11 citations
ACR Appropriateness criteria® for nasopharyngeal carcinoma
Nabil F. Saba, Joseph K. Salama, Jonathan J. Beitler, Paul M. Busse, Jay S. Cooper, Christopher U. Jones, Shlomo A. Koyfman, Harry Quon, John A. Ridge, Farzan Siddiqui...> ;Head & Neck. 2016 Jul 1
18 citations
ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck.
Shlomo A. Koyfman, Jay S. Cooper, Jonathan J. Beitler, Paul M. Busse, Christopher U. Jones, Mark W. McDonald, Harry Quon, John A. Ridge, Nabil F. Saba, Joseph K. Salam...> ;Head & Neck. 2016 Feb 1
Join now to see all

Committees

Member, Co-author, Committee on Appropriateness Criteria, Expert Panel on Radiation Oncology - Head & Neck Cancer, American College of Radiology 2015 - Present